FAST NEWS: Biotech Startup Sciwind Lands $70 Million in New Funding
The latest: Biotech startup Hangzhou Sciwind Biosciences Co. Ltd. announced it has closed its third funding round, raising 450 million yuan ($70 million). New backers in the latest round included…
RELATED ARTICLES
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK - Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
No respite for RemeGen as problems and losses pile up
9995.HK 688331.SHG
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
